# SORT OUT X - Combo Stent Versus ORSIRO Stent

Study · id `cardio:ct-nct03216733` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03216733](<https://clinicaltrials.gov/study/NCT03216733>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03216733

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 3148 participants.

## Technical summary

Registry record NCT03216733. Randomized; no masking; primary purpose treatment. Start 2017-06-01 (actual); primary completion 2018-11-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 3148 participants (enrolled count; ClinicalTrials.gov record NCT03216733, source copy `cardio:ctgov-nct03216733-2023-11-28`, retrieved 2026-10-26)
- Started: 2017-06-01 (actual) (ClinicalTrials.gov record NCT03216733, source copy `cardio:ctgov-nct03216733-2023-11-28`, retrieved 2026-10-26)
- Primary completion: 2018-11-30 (actual) (ClinicalTrials.gov record NCT03216733, source copy `cardio:ctgov-nct03216733-2023-11-28`, retrieved 2026-10-26)
- Completion: 2028-12-31 (anticipated) (ClinicalTrials.gov record NCT03216733, source copy `cardio:ctgov-nct03216733-2023-11-28`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT03216733, source copy `cardio:ctgov-nct03216733-2023-11-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03216733-2023-11-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: SORT OUT X - Combo Stent Versus ORSIRO Stent
- Acronym: SORT OUT X
- Condition: Coronary Heart Disease
- Condition: Angina Pectoris
- Condition: Myocardial Infarction
- Intervention (Device): COMBO
- Intervention (Device): ORSIRO
- Lead sponsor: Aarhus University Hospital Skejby
- Lead sponsor class: OTHER
- Collaborator: Biotronik SE & Co. KG
- Collaborator class: INDUSTRY
- Collaborator: OrbusNeich
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Angina pectoris (`cardio:angina-pectoris`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: Aarhus University Hospital Skejby (`cardio:org-aarhus-university-hospital-skejby`)
- Registry lists this organization as a collaborator: Biotronik SE & Co. KG (`cardio:org-biotronik-se-co-kg`)
- Registry lists this organization as a collaborator: OrbusNeich (`cardio:org-orbusneich`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Randomized Clinical Comparison of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent With the Sirolimus-Eluting Orsiro Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT X Trial (`cardio:pubmed-33823606`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Dual-therapy CD34 antibody-covered sirolimus-eluting COMBO stents versus sirolimus-eluting Orsiro stents in patients treated with percutaneous coronary intervention: the three-year outcomes of the SORT OUT X randomised clinical trial (`cardio:pubmed-37584207`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 8cacefa907ce05730aada409854827653b23f16a3939124da60a6af10e7e5207
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
